title: Terlipressin avoids hemodialysis in the treatment of refractory hyperkalemia associated with renal dysfunction in cirrhosis.
authors.affiliation: Department of Internal Medicine, Medical School of Ioannina, Greece.
authors.forename: Georgios
authors.initials: G
authors.lastname: Kalambokis
authors.forename: Haralampos
authors.initials: H
authors.lastname: Milionis
authors.forename: Moses
authors.initials: M
authors.lastname: Elisaf
authors.forename: Epameinondas V
authors.initials: EV
authors.lastname: Tsianos
mesh_terms: D006530:Hepatorenal Syndrome / Q000150:complications*; D006801:Humans; D006947:Hyperkalemia / Q000188:drug therapy* / Q000209:etiology*; D008103:Liver Cirrhosis / Q000150:complications*; D008236:Lypressin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012076:Renal Agents / Q000627:therapeutic use*; D000077585:Terlipressin
chemical_list: D012076:Renal Agents; D008236:Lypressin; D000077585:Terlipressin